TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05453578

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9 percent sodium chloride

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: WRAIR-PAM-CF1
Description: Bacteriophage combination composed of the following phages: PaWRA01Phi11, PaWRA01Phi39, PaWRA02Phi83, and PaWRA02Phi87.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: WRAIR-PAM-CF1
Description: Bacteriophage combination composed of the following phages: PaWRA01Phi11, PaWRA01Phi39, PaWRA02Phi83, and PaWRA02Phi87.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: WRAIR-PAM-CF1
Description: Bacteriophage combination composed of the following phages: PaWRA01Phi11, PaWRA01Phi39, PaWRA02Phi83, and PaWRA02Phi87.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: WRAIR-PAM-CF1
Description: Bacteriophage combination composed of the following phages: PaWRA01Phi11, PaWRA01Phi39, PaWRA02Phi83, and PaWRA02Phi87.
Study: NCT05233800

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Faster Asleep Smart Speaker Program
Description: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Faster Asleep Website
Description: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Study: NCT06162936

Intervention type: DIAGNOSTIC_TEST
Intervention: Phagoburst
Description: The main objective is to perform oxidative burst activity in pediatric patients with a definitive diagnosis of IBD and compare them with healthy controls.

Intervention type: DIAGNOSTIC_TEST
Intervention: Lymphocytes subsets
Description: To determine lymphocytes subsets in patients with suspicion of IEI

Intervention type: DIAGNOSTIC_TEST
Intervention: Genetic testing
Description: Perform targeted genetic testing in those with reduced to absent oxidative activity in search of PIDs and susceptibility variants
Study: NCT06446947

Intervention type: OTHER
Intervention: blood sampling
Description: Blood sampling (6ml) on admission and a second on discharge from intensive care.

Intervention type: OTHER
Intervention: blood sampling
Description: Blood sampling (6ml) on admission and a second on discharge from intensive care.
Study: NCT05735483

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Description: Administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered SC
Study: NCT05258526

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home based exercise training
Description: The intervention will be based on a remote approach, lasting 12 weeks. The training routine will consist of aerobic (walking), muscle strengthening and stretching exercises, with a frequency of three days per week. The contents related to the exercise prescription will be made available by phone call, text messages and short videos for exercise demonstration.
Study: NCT05320536

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Guilingji Capsule
Description: This medicine is capsule medicine, take method is oral.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This medicine is capsule medicine（Placebo）, take method is oral.
Study: NCT05681897

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Platelet-Rich Plasma Injections (PRP) on the Scalp
Description: each subject will be treated with 3x PRP injections on the scalp with 2 weeks interval in addition to daily minoxidil administration.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Platelet-Rich Plasma Injections (PRP) on the Scalp
Description: each subject will be treated with 3x PRP injections on the scalp with 2 weeks interval in addition to daily minoxidil administration.
Study: NCT05408234

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smart Foot Exercise
Description: The patient lies supine (supine) with the legs raised 450 while supported for 1-3 minutes until blanching occurs (the skin becomes pale).~The patient sits on the edge of the bed with the legs hanging down and then performs dorsiflexion, plantarflexion, inversion, and eversion for 3 minutes until the skin appears red.~The patient lies supine with the legs covered with a blanket for 3-5 minutes. This whole cycle is repeated 3-6 times per session, and each session is repeated 2-4 times a day.~Movement using newspaper media, namely by:~Place a sheet of newspaper on the floor, then shape the sheet into a ball with both feet.~The ball shape is then opened into a sheet as before with both feet. Tear the newspaper into two parts, and separate the two parts of the newspaper. Tear the first newspaper into small pieces with both feet. Remove the bunch of stubs and place them in a second, whole newspaper. Wrap everything into a ball shape with both feet. This step is enough to do once.
Study: NCT06010537

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: polysaccharide superparamagnetic iron oxide injection
Description: Polysaccharide superparamagnetic iron oxide injection is a magnetic resonance contrast agent.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: polysaccharide superparamagnetic iron oxide injection
Description: Polysaccharide superparamagnetic iron oxide injection is a magnetic resonance contrast agent.
Study: NCT06384625

Intervention type: OTHER
Group type: OTHER
Intervention: AIRWISE
Description: AIRWISE (Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education) utilizes personal air cleaners (PACs) to filter indoor air, while enhanced aspects focus on improving compliance to PAC use. Key components include low-cost sensors (PurpleAir, Inc, USA) that change color according to air quality index (AQI) and behavioral recommendations that correspond to varying AQI levels.
Study: NCT06434090

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal irinotecan
Description: Liposomal irinotecan will be given biweekly at a dose from 70mg/m2 to 90mg/m2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: bevacizumab will be given biweekly at a dose of 5mg/m2
Study: NCT05343845

Intervention type: OTHER
Intervention: Observational study
Description: After approval of the institution's ethics committee, 100 patients will be divided in two groups as pregnant women who did not smoke during pregnancy and pregnant women who smoked 5 or more cigarettes in a day. The local anesthetic, which dose will adjusted according to height and weight, and 20 µg fentanyl will be administered intrathecally to both groups. Results on the effectiveness of spinal anesthesia will be monitored.

Intervention type: OTHER
Intervention: Observational study
Description: After approval of the institution's ethics committee, 100 patients will be divided in two groups as pregnant women who did not smoke during pregnancy and pregnant women who smoked 5 or more cigarettes in a day. The local anesthetic, which dose will adjusted according to height and weight, and 20 µg fentanyl will be administered intrathecally to both groups. Results on the effectiveness of spinal anesthesia will be monitored.
Study: NCT05255705

Intervention type: OTHER
Intervention: Observation only
Description: Observation only
Study: NCT05729516

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hope App immersive learning and telehealth platform
Description: As part of the Hope App intervention, participants attend 10 skills sessions related to diabetes self-management. ITG participants will also receive monthly health coaching calls. After 6 months of active participation, participants enter a maintenance period, during which programming concludes but continued access to the program materials remains.
Study: NCT06111807

Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA
Description: ctDNA will be tested retrospectively, no treatment decisions will be made prospectively

Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA
Description: ctDNA will be tested retrospectively, no treatment decisions will be made prospectively

Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA
Description: ctDNA will be tested retrospectively, no treatment decisions will be made prospectively
Study: NCT05182905

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1390
Description: Phase 0: AZD1390 administered orally daily for 3 days prior to resection~Phase 1b: AZD1390 administered daily for 5 days concurrently with standard of care radiation therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1390
Description: Phase 0: AZD1390 administered orally daily for 3 days prior to resection~Phase 1b: AZD1390 administered daily for 5 days concurrently with standard of care radiation therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1390
Description: Phase 0: AZD1390 administered orally daily for 3 days prior to resection~Phase 1b: AZD1390 administered daily for 5 days concurrently with standard of care radiation therapy
Study: NCT04790422

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary fiber supplement
Description: Dietary fiber

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary fiber supplement
Description: Dietary fiber

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary fiber supplement
Description: Dietary fiber

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Caseine protein hydrolisate
Description: Dietary supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltrodextrine
Description: Placebo comparator
Study: NCT06557447

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Immunological and microbiological sample of peri-implant crevicular fluid; clinical evaluation
Description: Immunological sample collection involves placing a Periopaper strip in the peri-implantar sulcus for 30 seconds. If sample is contaminated with blood, sample will be discarded and another sample will be collected (a different surface of the same implant/tooth can be used).~Microbiological sample collection involves collecting subgingival dental plaque by sliding the end of the STERILE curette (Gracey) inside the peri-implant sulcus. In case of slight bleeding following the first sample, dry the site again before collection. In case of profuse bleeding, collect a sample from another site (by site mean mesial/buccal/distal/lingual) of the same implant.~Both immunological and microbiological samples will be sent for respective laboratories for the analysis.~Clinical evaluation will assess presence of dental plaque, bleeding on probing and gingival status.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Immunological and microbiological sample of peri-implant crevicular fluid; clinical evaluation
Description: Immunological sample collection involves placing a Periopaper strip in the peri-implantar sulcus for 30 seconds. If sample is contaminated with blood, sample will be discarded and another sample will be collected (a different surface of the same implant/tooth can be used).~Microbiological sample collection involves collecting subgingival dental plaque by sliding the end of the STERILE curette (Gracey) inside the peri-implant sulcus. In case of slight bleeding following the first sample, dry the site again before collection. In case of profuse bleeding, collect a sample from another site (by site mean mesial/buccal/distal/lingual) of the same implant.~Both immunological and microbiological samples will be sent for respective laboratories for the analysis.~Clinical evaluation will assess presence of dental plaque, bleeding on probing and gingival status.
Study: NCT05122832

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)

Intervention type: DIAGNOSTIC_TEST
Intervention: STEPwise Approach to NCD Risk Factor Surveillance (STEPS)
Description: The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.

Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometry
Description: Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.
Study: NCT06297161

Intervention type: DRUG
Intervention: Bosulif
Description: chronic myelogenous leukemia patients
Study: NCT05501301

Intervention type: OTHER
Intervention: IS weaning off
Description: IS weaning off will be conducted in recipients with chronic virus infection or side effects of IS
Study: NCT06419595

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information
Description: Description: Description: Participants who interact with a QR code and express interest in participating will be randomized to receive either: 1) recruitment from a Research Coordinator (standard research staff approach) or 2) recruitment from an EYE for Prevention Youth Researcher. The process of consent, screening, providing feedback, and offering access to a Single Session Intervention and information on additional resources (per scoring on the screening into Tier 1 (low risk/normal), 2 (moderate/at risk), or 3 (high/clinical risk): Tier 1 = screening+feedback; Tier 2=screening+feedback+SSI; Tier 3=screening+feedback+SSI+resource information) will be the same in each group. The randomization is simply changing who provides the process and platform to the participant.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information
Description: Description: Description: Participants who interact with a QR code and express interest in participating will be randomized to receive either: 1) recruitment from a Research Coordinator (standard research staff approach) or 2) recruitment from an EYE for Prevention Youth Researcher. The process of consent, screening, providing feedback, and offering access to a Single Session Intervention and information on additional resources (per scoring on the screening into Tier 1 (low risk/normal), 2 (moderate/at risk), or 3 (high/clinical risk): Tier 1 = screening+feedback; Tier 2=screening+feedback+SSI; Tier 3=screening+feedback+SSI+resource information) will be the same in each group. The randomization is simply changing who provides the process and platform to the participant.
Study: NCT04485468

Intervention type: OTHER
Intervention: Questionnaire
Description: The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.
Study: NCT05319223

Intervention type: BEHAVIORAL
Intervention: patient blood management
Description: three pillars of patient blood management will be applied
Study: NCT05326568

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Complementary treatment practice
Description: Applying sesame oil to the patients assigned to the intervention group by applying 10 drops to the 10 cm circumference of the cannula for 10 minutes
Study: NCT05911737

Intervention type: BEHAVIORAL
Intervention: Short video and Questionnaire
Description: A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video

Intervention type: BEHAVIORAL
Intervention: Short video and Questionnaire
Description: A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video
Study: NCT04904341

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Description: neuroprotection treatment
Study: NCT05185219

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Valerian
Description: A natural plant

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valerian
Description: A natural plant
Study: NCT05795868

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compression stocks
Description: Pregnant women in the compression stockings group will wear the socks given for 3 weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Knee socks
Description: Pregnant women in the Knee socks group will wear the socks given for 3 weeks.
Study: NCT05308082

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance Movement Therapy (DMT)
Description: The main Dance Movement Therapy (DMT) methods were dance-movement improvisations, body awareness exercises, and reflection through drawing/painting, writing, and verbalization. There was an orientation to personal space and body awareness, interaction in pairs, and interaction in the whole group. The themes included exploration of boundaries, somatic resources, symbols, pleasant and unpleasant emotions, mindfulness, and body awareness, enriched movement experiences, and safety and touch. In the present study, it consists of six sessions, including (1) Movement for Self-expression, (2) Movement for Emotional Health I, (3) Movement for Emotional Health II, (4) Movement for Connection \& Creativity, (5) Embracing your Dancing Child, and (6) Movement for Self-compassion.
Study: NCT05342142

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic and ResistanceExercise
Description: Exercise program consisting of 12 weeks of aerobic and resistance exercises
Study: NCT05180084

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Description: Internet-based CBT intervention based on CBT theory, self-determination theory and self-compassion therapy for low self-esteem among young adults.
Study: NCT04620928

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Concepts
Description: Images and sounds that are characteristic of various common objects.
Study: NCT04903990

Intervention type: OTHER
Intervention: Blood sample
Description: As part of the treatment, 2 EDTA tubes of 10mL will be taken during a scheduled venipuncture as part of the preoperative assessment.

Intervention type: OTHER
Intervention: Blood sample
Description: As part of the treatment, 2 EDTA tubes of 10mL will be taken during a scheduled venipuncture as part of the preoperative assessment.
Study: NCT06236763

Intervention type: DEVICE
Intervention: TOFscan foot
Description: TOFscan will be applied on the foot and recovery from neuromuscular blockade will be observed over time. These will be compared with the control (TOFscan at the hand) on the same patient (gold standard monitor).
Study: NCT05847582

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard inpatient psychiatric care
Description: All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard inpatient psychiatric care
Description: All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
Study: NCT04749160

Intervention type: DEVICE
Intervention: Connected device
Description: Connected device is a smart watch (with accelerometer without location data).
Study: NCT05551910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: The patients in the test group were given esmketamine (50mg / 2ml \* branch, Jiangsu Hengrui Pharmaceutical Co., Ltd.) 0.15-0.5mg/kg H was pumped intravenously. Two minutes after the administration, the pain was scored with the cpot pain observation scale. The target cpot was \< 3 points. The dose of esketamine was adjusted according to the cpot score.

Intervention type: DRUG
Group type: OTHER
Intervention: Remifentanil
Description: Patients in the control group were given remifentanil (1mg / branch, Yichang humanwell Pharmaceutical Co., Ltd.) 0.05-2ug/kg Minutes after administration, the analgesic score was measured with cpot pain observation scale. The target cpot was less than 3 points, and the dose of remifentanil was adjusted according to the cpot score.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propofol
Description: propofol

Intervention type: DRUG
Group type: OTHER
Intervention: propofol
Description: propofol
Study: NCT05847582

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard inpatient psychiatric care
Description: All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Inpatient Skills Training
Description: Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP. Skills training includes content designed to improve emotional regulation skills.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inpatient Skills Training
Description: Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP. Skills training includes content designed to improve emotional regulation skills.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth-supported Skills Training for Alcohol-Related Suicidality (mSTARS)
Description: mSTARS includes inpatient skills training and a mobile health (mHealth) telephone app designed to encourage participants to apply skills acquired in inpatient skills training to real-life situations.
Study: NCT04783766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CK-3773274
Description: CK-3773274- Tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CK-3773274
Description: CK-3773274- Tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo- Tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo- Tablets